Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nomida.biz
WARNING LETTER
•Nomida.biz•September 24, 2024

Nomida.biz – FDA Warning Letter, Sep 24, 2024

Record Details

On September 12, 2024, the FDA issued a Warning Letter to www.nomida.biz for unlawfully selling unapproved and misbranded new drugs, specifically semaglutide and tirzepatide products, to U.S. consumers over the internet. The FDA's review of the website revealed violations of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

The identified violations include the introduction of unapproved new drugs into interstate commerce. Nomida.biz offers semaglutide products (e.g., "SEMAGLUTIDE (10MG)", "SEMAGLUTIDE 10/4 mg/ml (GLP-1)") and tirzepatide products (e.g., "TIRZEPATIDE (10MG & 60MG)", "TIRZEPATIDE 10/1 mg/ml (GLP-1+GIP)") for weight management. These products lack FDA approval, unlike their prescription-only, FDA-approved counterparts (Ozempic, Wegovy, Rybelsus for semaglutide; Mounjaro, Zepbound for tirzepatide), which carry boxed warnings for serious risks like thyroid C-cell tumors.

Furthermore, the

Company
Nomida.biz
Inspection date
September 24, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Leigh Verbois (Director)
View Company Profile

ID · b5964a71-355a-40c1-a95f-00c1e9f78a5d

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 CFR 201.521 CFR 201.115(a)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nomida.biz
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.